×
The Standard e-Paper
Fearless, Trusted News
The Standard Group Plc is a
multi-media organization with investments in media platforms spanning newspaper
print operations, television, radio broadcasting, digital and online services. The
Standard Group is recognized as a leading multi-media house in Kenya with a key
influence in matters of national and international interest.
In vitro fertilisation (IVF) is an established and effective treatment for infertility. Alongside standard IVF protocols, many clinics now offer so-called "add-ons", which are supplementary tests or treatments intended to improve success rates. While some may be appropriate in specific clinical contexts, others remain experimental or of uncertain benefit. Patients should approach these options with scrutiny.
IVF add-ons are offered in addition to conventional, well-established treatments. They usually come at extra cost and are marketed as improving implantation, reducing miscarriage, or enhancing embryo selection. Common examples include preimplantation genetic testing for chromosomal errors (PGT-A), time-lapse embryo imaging incubator systems, assisted hatching, and immune therapies, such as intralipids and steroids.
Subscribe to our newsletter and stay updated on the latest developments and special offers!
Prefer the Standard on Google
join